Aeras, the non-profit organisation working out of bases in both the US and South Africa, has received a grant up to $220 million over five years from the Bill and Melinda Gates Foundation for further development of new vaccines for tuberculosis (TB). The grant extends the Gates Foundation's long time backing of Aeras, which has also received funds from government bodies.
Focusing exclusively on TB, the non-profit has a pipeline of candidates being developed through pharmaceutical and academic partnerships,. "We have...